Head-to-head

BPC-157 vs GHK-Cu

A neutral, evidence-first comparison of BPC-157 and GHK-Cu — mechanism, approval status, research, and safety.

BPC-157 and GHK-Cu are both popular "repair" peptides, but they're used in completely different ways. BPC-157 is an injected research chemical studied (in animals) for tendon and gut healing; GHK-Cu is a topical copper peptide used as a cosmetic skincare ingredient for collagen and skin appearance. Different routes, different goals, different evidence.

Educational only — not medical advice. Comparisons summarize published research and do not recommend any compound. Consult a qualified clinician.

At a glance

BPC-157GHK-Cu
What it isGastric pentadecapeptideCopper-binding tripeptide
Typical useInjected for soft-tissue/gut healing (research)Topical skincare ingredient
Regulatory statusUnapproved research chemicalUsed as a cosmetic ingredient
EvidenceAnimal studies; no human trialsCosmetic studies for skin appearance
RouteInjectionTopical (serums, creams)
Sport statusBanned (WADA)Not a typical doping concern

The bottom line

Bottom line: These barely overlap in practice. BPC-157 is an injectable research chemical for systemic tissue healing with only animal evidence and no human trials. GHK-Cu is a topical cosmetic peptide with modest, gradual effects on skin appearance and a long history as a skincare ingredient. The right comparison depends entirely on what you're asking it to do.

Read the full guides: BPC-157 · GHK-Cu

Frequently asked questions

Are BPC-157 and GHK-Cu used the same way?

No. BPC-157 is typically injected and studied for internal tissue and gut healing, while GHK-Cu is applied topically as a cosmetic skincare ingredient for skin firmness and appearance.

Which has better evidence?

GHK-Cu has cosmetic studies supporting modest skin-appearance benefits and is widely used as a skincare ingredient. BPC-157 relies on animal data with no completed human trials and is unapproved.

Is GHK-Cu safer than BPC-157?

Topical GHK-Cu in cosmetics has a long use history with generally modest effects, whereas injected BPC-157 is an unapproved research chemical with unknown human safety. They serve very different purposes.

References

Combined peer-reviewed sources from both peptide guides. Inclusion is not endorsement.

  1. Hsieh MJ, Liu HT, Wang CN, et al. Therapeutic potential of pro-angiogenic BPC157 is associated with VEGFR2 activation and up-regulation. J Mol Med (Berl). 2017. Peer-reviewed study
  2. Cerovecki T, Bojanic I, Brcic L, et al. Pentadecapeptide BPC 157 (PL 14736) improves ligament healing in the rat. J Orthop Res. 2010. Peer-reviewed study
  3. Hsieh MJ, Lee CH, Chueh HY, et al. Modulatory effects of BPC 157 on vasomotor tone and the activation of Src-Caveolin-1-eNOS pathway. Sci Rep. 2020. Peer-reviewed study
  4. Józwiak M, Bauer M, Kamysz W, et al. Multifunctionality and Possible Medical Application of the BPC 157 Peptide-Literature and Patent Review. Pharmaceuticals (Basel). 2025. Peer-reviewed study
  5. Gwyer D, Wragg NM, Wilson SL. Gastric pentadecapeptide body protection compound BPC 157 and its role in accelerating musculoskeletal soft tissue healing. Cell Tissue Res. 2019. Peer-reviewed study
  6. Vasireddi N, Hahamyan H, Salata MJ, et al. Emerging Use of BPC-157 in Orthopaedic Sports Medicine: A Systematic Review. HSS J. 2025. Peer-reviewed study
  7. Pickart L, Margolina A. Regenerative and Protective Actions of the GHK-Cu Peptide in the Light of the New Gene Data. Int J Mol Sci. 2018. Peer-reviewed study
  8. Pickart L, Vasquez-Soltero JM, Margolina A. GHK Peptide as a Natural Modulator of Multiple Cellular Pathways in Skin Regeneration. Biomed Res Int. 2015. Peer-reviewed study
  9. Pickart L, Vasquez-Soltero JM, Margolina A. The Human Tripeptide GHK-Cu in Prevention of Oxidative Stress and Degenerative Conditions of Aging. Oxid Med Cell Longev. 2012. Peer-reviewed study
  10. Ogórek K, Nowak K, Wadych E, et al. Are We Ready to Measure Skin Permeation of Modern Antiaging GHK-Cu Tripeptide Encapsulated in Liposomes?. Molecules. 2025. Peer-reviewed study
  11. Dymek M, Olechowska K, Hąc-Wydro K, et al. Liposomes as Carriers of GHK-Cu Tripeptide for Cosmetic Application. Pharmaceutics. 2023. Peer-reviewed study
  12. Sahu R, Yadav S, Gunturu KC, et al. Phenothiazine-Based Cu(II)-Selective Fluorescent Sensor: GHK-Cu Sensing Applications. J Org Chem. 2023. Peer-reviewed study

Educational content only — not medical advice. See our Privacy Policy.